OCULAR THERAPEUTIX INC (OCUL) Institutional Ownership Changes & 13F Activity

OCULAR THERAPEUTIX INC (OCUL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Fmr Llc, Avoro Capital Advisors Llc, Venrock Adviser, Llc, Tcg Crossover Management, Llc, and Adage Capital Partners Gp, L.L.C..

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Catalio Capital Management, LpBuy+714,501—714,501$8.67MQ4 2025Sep 02, 2026
Algert Global LlcBuy+127,410—127,410$1.55MQ4 2025Aug 11, 2026
Seven Fleet Capital Management LpBuy+17,100—17,100$207.59KQ4 2025Feb 26, 2026
Td Capital Management LlcBuy+47—47$571.00Q4 2025Feb 26, 2026
Virtu Financial LlcBuy+65,627—65,627$797.00KQ4 2025Feb 23, 2026
Corient Private Wealth LlcBuy+30,215—30,215$366.81KQ4 2025Feb 19, 2026
Raymond James Financial IncBuy+842,187—842,187$10.22MQ4 2025Feb 18, 2026
Mackenzie Financial CorpBuy+10,903—10,903$132.75KQ4 2025Feb 18, 2026
Newedge Advisors, LlcBuy+1,000—1,000$12.14KQ4 2025Feb 18, 2026
Fmr LlcBuy+31,785,605—31,785,605$385.88MQ4 2025Feb 17, 2026
Avoro Capital Advisors LlcBuy+10,777,777—10,777,777$130.84MQ4 2025Feb 17, 2026
Venrock Adviser, LlcBuy+7,315,547—7,315,547$88.81MQ4 2025Feb 17, 2026
Tcg Crossover Management, LlcBuy+5,740,231—5,740,231$69.69MQ4 2025Feb 17, 2026
Adage Capital Partners Gp, L.L.C.Buy+4,625,050—4,625,050$56.15MQ4 2025Feb 17, 2026
Alliancebernstein L.P.Buy+4,341,951—4,341,951$52.71MQ4 2025Feb 17, 2026
Janus Henderson Group PlcBuy+4,229,202—4,229,202$51.32MQ4 2025Feb 17, 2026
Logos Global Management LpBuy+3,500,000—3,500,000$42.49MQ4 2025Feb 17, 2026
Millennium Management LlcBuy+3,207,881—3,207,881$38.94MQ4 2025Feb 17, 2026
Paradigm Biocapital Advisors LpBuy+2,935,284—2,935,284$35.63MQ4 2025Feb 17, 2026
Octagon Capital Advisors LpBuy+2,623,600—2,623,600$31.85MQ4 2025Feb 17, 2026
Citadel Advisors LlcBuy+2,475,849—2,475,849$30.06MQ4 2025Feb 17, 2026
Woodline Partners LpBuy+1,666,136—1,666,136$20.23MQ4 2025Feb 17, 2026
Opaleye Management Inc.Buy+1,595,000—1,595,000$19.36MQ4 2025Feb 17, 2026
Saturn V Capital Management LpBuy+1,504,880—1,504,880$18.27MQ4 2025Feb 17, 2026
Northern Trust CorpBuy+1,462,503—1,462,503$17.75MQ4 2025Feb 17, 2026
D. E. Shaw & Co., Inc.Buy+1,153,910—1,153,910$14.01MQ4 2025Feb 17, 2026
Artisan Partners Limited PartnershipBuy+1,063,371—1,063,371$12.91MQ4 2025Feb 17, 2026
Acuta Capital Partners, LlcBuy+1,052,995—1,052,995$12.78MQ4 2025Feb 17, 2026
Point72 Asset Management, L.P.Buy+1,016,248—1,016,248$12.34MQ4 2025Feb 17, 2026
Voloridge Investment Management, LlcBuy+812,078—812,078$9.86MQ4 2025Feb 17, 2026
Showing 30 of 240

Frequently asked questions about OCUL activity

  • Which institutional owners are buying OCUL?

    Institutional owners buying OCUL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in OCUL activity?

    "Buy" means an investor increased their reported position in OCUL compared to the prior reporting period. This reflects growing exposure to OCULAR THERAPEUTIX INC (OCUL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in OCUL increasing?

    Institutional interest in OCUL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.